UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
PHARMA INVESTING NEWS, INC.
(Exact name of registrant as specified in its charter)
Nevada |
| 333-174271 |
| 32-0337695 |
(State or other jurisdiction |
| (Commission File Number) |
| (IRS Employer |
of Incorporation) |
|
|
| Identification Number) |
|
|
|
|
|
|
| 1810 East Sahara Ave Suite 1571 Las Vegas, NV 89104 (Address of principal executive offices)
(702) 664-6555 (Registrants telephone number) |
|
|
|
|
|
|
|
Securities to be registered pursuant to Section 12(b) of the Act: None
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. .
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. X .
Securities Act registration statement file number to which this form relates: 333-174271
Securities to be registered pursuant to Section 12(g) of the Act:
Title of each class
to be so registered
___________________________________________________
Common Shares, par value $0.001 per share
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrants Securities to be Registered
Pharma Investing News, Inc. (the Registrant) hereby incorporates by reference the description of its common stock to be registered hereunder in the section captioned Description of Securities in the Registrants Registration Statement on Form S-1/A (File No. 333-174271), as amended and filed with the U.S. Securities and Exchange Commission (the Commission) on August 30, 2011 (the Registration Statement).
Item 2. Exhibits
The following exhibits are incorporated herein by reference:
Exhibit | Description | Reference | ||
| ||||
3.01 | Articles of Incorporation | Filed with the SEC on May 17, 2011 as part of our Registration Statement on Form S-1. | ||
3.02 | ByLaws | Filed with the SEC on May 17, 2011 as part of our Registration Statement on Form S-1. |
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
PHARMA INVESTING NEWS, INC.
Date: June 15, 2012
By: /s/ Robert Lawrence
Name: Robert Lawrence
Title: President and Chief Executive Officer